Importer of Controlled Substances Registration: Cerilliant Corporation, 15568-15571 [2016-06548]
Download as PDF
15568
Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the following basic
classes of controlled substances:
its customers. Dihydromorphine is an
intermediate in the manufacture of
Hydromorphone and is not for
commercial distribution.
Dated: March 14, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–06532 Filed 3–22–16; 8:45 am]
BILLING CODE 4410–09–P
Controlled substance
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Cambrex
Charles City
ACTION:
Notice of registration.
Cambrex Charles City applied
to be registered as a manufacturer of
certain basic classes of controlled
substances. The Drug Enforcement
Administration (DEA) grants Cambrex
Charles City registration as a
manufacturer of those controlled
substances.
SUPPLEMENTARY INFORMATION: By notice
dated October 13, 2015, and published
in the Federal Register on October 21,
2015, 80 FR 63835, Cambrex Charles
City, 1205 11th Street, Charles City,
Iowa 50616 applied to be registered as
a manufacturer of certain basic classes
of controlled substances. No other
comments or objections were submitted
for this notice.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of Cambrex Charles City
to manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
SUMMARY:
Amphetamine (1100) ....................
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
4-Anilino-N-phenethyl-4-piperidine
(ANPP) (8333).
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Opium extracts (9610) ..................
Opium fluid extract (9620) ............
Opium tincture (9630) ..................
Opium, powdered (9639) .............
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Fentanyl (9801) ............................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers, for dosage form
development, for clinical trials, and for
use in stability qualification studies.
Dated: March 14, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–06536 Filed 3–22–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Cerilliant Corporation applied
to be registered as an importer of certain
basic classes of controlled substances.
The Drug Enforcement Administration
(DEA) grants Cerilliant Corporation
registration as an importer of those
controlled substances.
SUMMARY:
By notice
dated October 13, 2015, and published
in the Federal Register on October 21,
2015, 80 FR 63836, Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402 applied
to be registered as an importer of certain
basic classes of controlled substances.
Comments and requests for hearing on
applications to import narcotic raw
material are not appropriate. 72 FR
3417, (January 25, 2007). No comments
or objections were submitted for this
notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Cerilliant Corporation to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Cerilliant Corporation
ACTION:
Notice of registration.
jstallworth on DSK7TPTVN1PROD with NOTICES
Controlled substance
Schedule
3-Fluoro-N-methylcathinone (3–FMC) (1233) .............................................................................................................................................
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) (1238) .............................................................................................................................................
Pentedrone (a-methylaminovalerophenone) (1246) ....................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) (1248) ....................................................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) (1249) ................................................................................................................................................
Naphyrone (1258) ........................................................................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
N,N-Dimethylamphetamine (1480) ..............................................................................................................................................................
Fenethylline (1503) ......................................................................................................................................................................................
Methaqualone (2565) ..................................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) (6250) ...................................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) (7008) .................................................................
VerDate Sep<11>2014
15:26 Mar 22, 2016
Jkt 238001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
E:\FR\FM\23MRN1.SGM
23MRN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
15569
Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
jstallworth on DSK7TPTVN1PROD with NOTICES
Controlled substance
Schedule
5-Flouro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (7011) ................................
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) (7012) .....................................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) (7019) ......................................................................................................................................
AB–PINACA (N-(1 amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) (7023) ..........................................................
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalene-1-yl)methanone (7024) .................................................................................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohenxylmethyl)-1H-indazole-3-carboxamide (7031) ...............................
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) (7035) .................................................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (7048) ...............................................................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)indole) (7081) ...................................................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole (7104) .....................................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) (7118) ..............................................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) (7122) ......................................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (7144) .................................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) (7173) .......................................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole) (7200) .........................................................................................................
AM–2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole) (7201) ......................................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) (7203) .......................................................................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) (7222) .................................................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) (7225) ............................................................................................
Alpha-ethyltryptamine (7249) ......................................................................................................................................................................
Ibogaine (7260) ...........................................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) (7297) .................................................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) (7298) ...........................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) (7348) ...............................................................................................................
Marihuana (7360) ........................................................................................................................................................................................
Parahexyl (7374) .........................................................................................................................................................................................
Mescaline (7381) .........................................................................................................................................................................................
2-(4-Elthylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) (7385) ...........................................................................................................
3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole (7398) .......................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine (7401) ..................................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) ..................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
5-Methoxy-N–N-dimethyltryptamine (7431) .................................................................................................................................................
Alpha-methyltryptamine (7432) ...................................................................................................................................................................
Bufotenine (7433) ........................................................................................................................................................................................
Diethyltryptamine (7434) .............................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
Psilocyn (7438) ............................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine (7439) ..............................................................................................................................................
N-Ethyl-1-phenylcyclohexylamine (7455) ....................................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine (7458) ....................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ...............................................................................................................................................
N-Benzylpiperazine (7493) ..........................................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) (7498) ......................................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) (7508) ..................................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E) (7509) .....................................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) (7517) .................................................................................................................................
2-(4-lodo-2,5-dimethoxyphenyl) ethanamine (2C–I) (7518) ........................................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) (7519) ...................................................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) (7521) ....................................................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) (7524) .............................................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4) (7532) ....................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) (7535) .......................................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) (7536) ....................................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) (7537) .....................................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) (7538) .........................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) (7540) .......................................................................................................................
Butylone (7541) ...........................................................................................................................................................................................
Pentylone (7542) .........................................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) (7545) .........................................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) (7546) ...........................................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) (7694) ....................................................................................................................
Desomorphine (9055) ..................................................................................................................................................................................
Etorphine (except HCI) (9056) ....................................................................................................................................................................
VerDate Sep<11>2014
15:26 Mar 22, 2016
Jkt 238001
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
E:\FR\FM\23MRN1.SGM
23MRN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
15570
Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
Controlled substance
Schedule
jstallworth on DSK7TPTVN1PROD with NOTICES
Codeine methylbromide (9070) ...................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Morphine-N-oxide (9307) .............................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Pholcodine (9314) .......................................................................................................................................................................................
Acetylmethadol (9601) .................................................................................................................................................................................
Allylprodine (9602) .......................................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol (9603) ......................................................................................................................
Alphameprodine (9604) ...............................................................................................................................................................................
Alphamethadol (9605) .................................................................................................................................................................................
Betacetylmethadol (9607) ............................................................................................................................................................................
Betameprodine (9608) .................................................................................................................................................................................
Betamethadol (9609) ...................................................................................................................................................................................
Betaprodine (9611) ......................................................................................................................................................................................
Dextromoramide (9613) ...............................................................................................................................................................................
Dipipanone (9622) .......................................................................................................................................................................................
Hydroxypethidine (9627) .............................................................................................................................................................................
Noracymethadol (9633) ...............................................................................................................................................................................
Norlevorphanol (9634) .................................................................................................................................................................................
Normethadone (9635) .................................................................................................................................................................................
Racemoramide (9645) .................................................................................................................................................................................
Trimeperidine (9646) ...................................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine (9661) .......................................................................................................................................
Tilidine (9750) ..............................................................................................................................................................................................
Para-Fluorofentanyl (9812) ..........................................................................................................................................................................
3-Methylfentanyl (9813) ...............................................................................................................................................................................
Alpha-Methylfentanyl (9814) ........................................................................................................................................................................
Acetyl-alpha-methylfentanyl (9815) .............................................................................................................................................................
Beta-hydroxyfentanyl (9830) .......................................................................................................................................................................
Beta-hydroxy-3-methylfentanyl (9831) ........................................................................................................................................................
Alpha-methylthiofentanyl (9832) ..................................................................................................................................................................
3-Methylthiofentanyl (9833) .........................................................................................................................................................................
Thiofentanyl (9835) ......................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Methylphenidate (1724) ...............................................................................................................................................................................
Amobarbital (2125) ......................................................................................................................................................................................
Pentobarbital (2270) ....................................................................................................................................................................................
Secobarbital (2315) .....................................................................................................................................................................................
Glutethimide (2550) .....................................................................................................................................................................................
Nabilone (7379) ...........................................................................................................................................................................................
1-Phenylcyclohexylamine (7460) .................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Phenylacetone (8501) .................................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................
Alphaprodine (9010) ....................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Ethylmorphine (9190) ..................................................................................................................................................................................
Levomethorphan (9210) ..............................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) (9273) ..............................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
Noroxymorphone (9668) ..............................................................................................................................................................................
Racemethorphan (9732) ..............................................................................................................................................................................
Alfentanil (9737) ..........................................................................................................................................................................................
Remifentanil (9739) .....................................................................................................................................................................................
Sufentanil (9740) .........................................................................................................................................................................................
Carfentanil (9743) ........................................................................................................................................................................................
Tapentadol (9780) .......................................................................................................................................................................................
The company plans to import small
quantities of the listed controlled
substances for the manufacture of
analytical reference standards and
distribution to their research and
forensic customers.
In reference to drug codes 7360 the
company plans to import a synthetic
cannabidiol. No other activity for this
VerDate Sep<11>2014
15:26 Mar 22, 2016
Jkt 238001
drug code is authorized for this
registration.
Placement of these drug codes onto
the company’s registration does not
translate into automatic approval of
subsequent permit applications to
import controlled substances.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
is authorized under to 21 U.S.C.
952(a)(2). Authorization will not extend
to the import of FDA approved or nonapproved finished dosage forms for
commercial sale.
E:\FR\FM\23MRN1.SGM
23MRN1
Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
Dated: March 14, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
DEPARTMENT OF LABOR
[FR Doc. 2016–06548 Filed 3–22–16; 8:45 am]
Occupational Safety and Health
Administration
BILLING CODE 4410–09–P
[Docket No. OSHA–2016–0008]
DEPARTMENT OF JUSTICE
Whistleblower Protection Advisory
Committee (WPAC)
Drug Enforcement Administration
AGENCY:
Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Announcement of a meeting of
WPAC.
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Patheon
Pharmaceuticals, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before
May 23, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
December 10, 2015, Patheon
Pharmaceuticals, Inc., 2110 E. Galbraith
Road, Cincinnati, Ohio 45237 applied to
be registered as a bulk manufacturer of
gamma hydroxybutyric acid (2010) a
basic class of controlled substance listed
in schedule I.
The company plans to manufacture
the listed controlled substance for
product development.
jstallworth on DSK7TPTVN1PROD with NOTICES
DATES:
Dated: March 14, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–06539 Filed 3–22–16; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
15:26 Mar 22, 2016
Jkt 238001
WPAC will meet April 26,
2016, in Washington, DC.
DATES: WPAC meeting: WPAC will meet
from 9:00 a.m. to 4:00 p.m., E.T.,
Tuesday, April 26, 2015.
Written comments, requests to speak,
speaker presentations, and requests for
special accommodation: You must
submit (postmark, send, transmit)
comments, requests to address the
WPAC meeting, speaker presentations
(written or electronic), and requests for
special accommodations for the WPAC
meeting by April 12, 2016.
ADDRESSES: WPAC meeting: WPAC will
meet in Room N–4437 A–C, U.S.
Department of Labor, Francis Perkins
Building, 200 Constitution Avenue NW.,
Washington, DC 20210.
Submission of comments, requests to
speak, and speaker presentations: You
may submit comments, requests to
speak at the WPAC meeting, and
speaker presentations using one of the
following methods:
Electronically: You may submit
materials, including attachments,
electronically at https://
www.regulations.gov, which is the
Federal eRulemaking Portal. Follow the
on-line instructions for submissions.
Facsimile (Fax): If your submission,
including attachments, does not exceed
10 pages, you may fax it to the OSHA
Docket Office at (202) 693–1648.
Regular mail, express mail, hand
delivery, or messenger (courier) service:
You may submit your materials to the
OSHA Docket Office, Docket No.
OSHA–2016–0008, Room N–2625, U.S.
Department of Labor, 200 Constitution
Avenue NW., Washington, DC 20210;
telephone (202) 693–2350 (TTY (877)
889–5627). OSHA’s Docket Office
accepts deliveries (hand deliveries,
express mail, and messenger service)
during normal business hours, 8:15
a.m.–4:45 p.m., E.T., weekdays.
Requests for special accommodations:
Please submit any requests for special
accommodations to attend the WPAC
meeting to Ms. Gretta Jameson, OSHA,
Office of Communications, Room N–
3647, U.S. Department of Labor, 200
SUMMARY:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
15571
Constitution Avenue NW., Washington,
DC 20210; telephone (202) 693–1999;
email jameson.grettah@dol.gov.
Instructions: Your submissions must
include the agency name and docket
number for this Federal Register notice
(Docket No. OSHA–2016–0008). Due to
security-related procedures,
submissions by regular mail may
experience significant delays. Please
contact the OSHA Docket Office for
information about security procedures
for making submissions. For additional
information on submitting comments,
requests to speak, and speaker
presentations, see the SUPPLEMENTARY
INFORMATION section of this notice.
FOR FURTHER INFORMATION CONTACT:
For press inquiries: Mr. Frank
Meilinger, Director, OSHA Office of
Communications, Room N–3647, U.S.
Department of Labor, 200 Constitution
Avenue NW., Washington, DC 20210;
telephone (202) 693–1999; email
meilinger.francis2@dol.gov.
For general information about WPAC
and WPAC meetings: Mr. Anthony Rosa,
OSHA, Directorate of Whistleblower
Protection Programs, Room N–4618,
U.S. Department of Labor, 200
Constitution Avenue NW., Washington,
DC 20210; telephone (202) 693–2199;
email osha.dwpp@dol.gov.
SUPPLEMENTARY INFORMATION:
WPAC Meeting
WPAC will meet Tuesday, April 26,
2015, in Washington, DC. WPAC
meetings are open to the public.
The tentative agenda of the WPAC
meeting includes:
Remarks from the Assistant Secretary of
Labor for Occupational Safety and Health
(OSHA);
Remarks from the Director of the Directorate
of Whistleblower Protection Programs;
Presentations from other federal agencies
with whistleblower programs;
Railroad worker whistleblower presentation;
Public comments;
Work Group presentations; and,
Old business.
OSHA transcribes WPAC meetings and
prepares detailed minutes of the
meetings. OSHA places the meeting
transcripts and minutes in the public
record of the WPAC meeting. The public
record also includes Work Group
reports, speaker presentations,
comments and other materials
submitted to WPAC.
WPAC Work Groups
The WPAC work groups (Outreach
and Training) will meet on April 25,
2016. These work group meetings will
be open to the public. The purpose of
the work groups is to provide
recommendations to the full WPAC
E:\FR\FM\23MRN1.SGM
23MRN1
Agencies
[Federal Register Volume 81, Number 56 (Wednesday, March 23, 2016)]
[Notices]
[Pages 15568-15571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06548]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration: Cerilliant
Corporation
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Cerilliant Corporation applied to be registered as an importer
of certain basic classes of controlled substances. The Drug Enforcement
Administration (DEA) grants Cerilliant Corporation registration as an
importer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated October 13, 2015, and
published in the Federal Register on October 21, 2015, 80 FR 63836,
Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas
78665-2402 applied to be registered as an importer of certain basic
classes of controlled substances. Comments and requests for hearing on
applications to import narcotic raw material are not appropriate. 72 FR
3417, (January 25, 2007). No comments or objections were submitted for
this notice.
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of Cerilliant Corporation
to import the basic classes of controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above-named company is granted
registration as an importer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC) (1233)... I
Cathinone (1235)............................ I
Methcathinone (1237)........................ I
4-Fluoro-N-methylcathinone (4-FMC) (1238)... I
Pentedrone (a-methylaminovalerophenone) I
(1246).
Mephedrone (4-Methyl-N-methylcathinone) I
(1248).
4-Methyl-N-ethylcathinone (4-MEC) (1249).... I
Naphyrone (1258)............................ I
N-Ethylamphetamine (1475)................... I
N,N-Dimethylamphetamine (1480).............. I
Fenethylline (1503)......................... I
Methaqualone (2565)......................... I
JWH-250 (1-Pentyl-3-(2- I
methoxyphenylacetyl)indole) (6250).
SR-18 (Also known as RCS-8) (1- I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl)indole) (7008).
[[Page 15569]]
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro- I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone (7011).
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- I
2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide) (7012).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) I
(7019).
AB-PINACA (N-(1 amino-3-methyl-1-oxobutan-2- I
yl)-1-pentyl-1H-indazole-3-carboxamide)
(7023).
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- I
yl](naphthalene-1-yl)methanone (7024).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan- I
2-yl)-1-(cyclohenxylmethyl)-1H-indazole-3-
carboxamide (7031).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide) (7035).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl- I
1H-indazole-3-carboxamide (7048).
JWH-081 (1-Pentyl-3-(1-(4- I
methoxynaphthoyl)indole) (7081).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- I
methoxy)-benzoyl] indole (7104).
JWH-018 (also known as AM678) (1-Pentyl-3-(1- I
naphthoyl)indole) (7118).
JWH-122 (1-Pentyl-3-(4-methyl-1- I
naphthoyl)indole) (7122).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- I
tetramethylcyclopropyl)methanone (7144).
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) I
(7173).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- I
naphthoyl) indole) (7200).
AM-2201 (1-(5-Fluoropentyl)-3-(1- I
naphthoyl)indole) (7201).
JWH-203 (1-Pentyl-3-(2- I
chlorophenylacetyl)indole) (7203).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- I
carboxylate) (7222).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- I
1H-indole-3-carboxylate) (7225).
Alpha-ethyltryptamine (7249)................ I
Ibogaine (7260)............................. I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)- I
3-hydroxycyclohexyl-phenol) (7297).
CP-47,497 C8 Homologue (5-(1,1- I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol) (7298).
Lysergic acid diethylamide (7315)........... I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine I
(2C-T-7) (7348).
Marihuana (7360)............................ I
Parahexyl (7374)............................ I
Mescaline (7381)............................ I
2-(4-Elthylthio-2,5-dimethoxyphenyl) I
ethanamine (2C-T-2) (7385).
3,4,5-Trimethoxyamphetamine (7390).......... I
4-Bromo-2,5-dimethoxyamphetamine (7391)..... I
4-Bromo-2,5-dimethoxyphenethylamine (7392).. I
4-Methyl-2,5-dimethoxyamphetamine (7395).... I
2,5-Dimethoxyamphetamine (7396)............. I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) I
indole (7398).
3,4-Methylenedioxyamphetamine (7400)........ I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405).... I
4-Methoxyamphetamine (7411)................. I
5-Methoxy-N-N-dimethyltryptamine (7431)..... I
Alpha-methyltryptamine (7432)............... I
Bufotenine (7433)........................... I
Diethyltryptamine (7434).................... I
Dimethyltryptamine (7435)................... I
Psilocybin (7437)........................... I
Psilocyn (7438)............................. I
5-Methoxy-N,N-diisopropyltryptamine (7439).. I
N-Ethyl-1-phenylcyclohexylamine (7455)...... I
1-(1-Phenylcyclohexyl)pyrrolidine (7458).... I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I
N-Benzylpiperazine (7493)................... I
4-Methyl-alphapyrrolidinopropiophenone (4- I
MePPP) (7498).
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine I
(2C-D) (7508).
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine I
(2C-E) (7509).
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) I
(7517).
2-(4-lodo-2,5-dimethoxyphenyl) ethanamine I
(2C-I) (7518).
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine I
(2C-C) (7519).
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine I
(2C-N) (7521).
2-(2,5-Dimethoxy-4-(n)-propylphenyl) I
ethanamine (2C-P) (7524).
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) I
ethanamine (2C-T-4) (7532).
MDPV (3,4-Methylenedioxypyrovalerone) (7535) I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- I
methoxybenzyl) ethanamine (25B-NBOMe)
(7536).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- I
methoxybenzyl) ethanamine (25C-NBOMe)
(7537).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- I
methoxybenzyl) ethanamine (25I-NBOMe)
(7538).
Methylone (3,4-Methylenedioxy-N- I
methylcathinone) (7540).
Butylone (7541)............................. I
Pentylone (7542)............................ I
alpha-pyrrolidinopentiophenone (a-PVP) I
(7545).
alpha-pyrrolidinobutiophenone (a-PBP) (7546) I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) I
indole) (7694).
Desomorphine (9055)......................... I
Etorphine (except HCI) (9056)............... I
[[Page 15570]]
Codeine methylbromide (9070)................ I
Heroin (9200)............................... I
Morphine-N-oxide (9307)..................... I
Normorphine (9313).......................... I
Pholcodine (9314)........................... I
Acetylmethadol (9601)....................... I
Allylprodine (9602)......................... I
Alphacetylmethadol except levo- I
alphacetylmethadol (9603).
Alphameprodine (9604)....................... I
Alphamethadol (9605)........................ I
Betacetylmethadol (9607).................... I
Betameprodine (9608)........................ I
Betamethadol (9609)......................... I
Betaprodine (9611).......................... I
Dextromoramide (9613)....................... I
Dipipanone (9622)........................... I
Hydroxypethidine (9627)..................... I
Noracymethadol (9633)....................... I
Norlevorphanol (9634)....................... I
Normethadone (9635)......................... I
Racemoramide (9645)......................... I
Trimeperidine (9646)........................ I
1-Methyl-4-phenyl-4-propionoxypiperidine I
(9661).
Tilidine (9750)............................. I
Para-Fluorofentanyl (9812).................. I
3-Methylfentanyl (9813)..................... I
Alpha-Methylfentanyl (9814)................. I
Acetyl-alpha-methylfentanyl (9815).......... I
Beta-hydroxyfentanyl (9830)................. I
Beta-hydroxy-3-methylfentanyl (9831)........ I
Alpha-methylthiofentanyl (9832)............. I
3-Methylthiofentanyl (9833)................. I
Thiofentanyl (9835)......................... I
Methamphetamine (1105)...................... II
Methylphenidate (1724)...................... II
Amobarbital (2125).......................... II
Pentobarbital (2270)........................ II
Secobarbital (2315)......................... II
Glutethimide (2550)......................... II
Nabilone (7379)............................. II
1-Phenylcyclohexylamine (7460).............. II
Phencyclidine (7471)........................ II
Phenylacetone (8501)........................ II
1-Piperidinocyclohexanecarbonitrile (8603).. II
Alphaprodine (9010)......................... II
Dihydrocodeine (9120)....................... II
Ecgonine (9180)............................. II
Ethylmorphine (9190)........................ II
Levomethorphan (9210)....................... II
Levorphanol (9220).......................... II
Meperidine (9230)........................... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Levo-alphacetylmethadol (9648).............. II
Noroxymorphone (9668)....................... II
Racemethorphan (9732)....................... II
Alfentanil (9737)........................... II
Remifentanil (9739)......................... II
Sufentanil (9740)........................... II
Carfentanil (9743).......................... II
Tapentadol (9780)........................... II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances for the manufacture of analytical reference
standards and distribution to their research and forensic customers.
In reference to drug codes 7360 the company plans to import a
synthetic cannabidiol. No other activity for this drug code is
authorized for this registration.
Placement of these drug codes onto the company's registration does
not translate into automatic approval of subsequent permit applications
to import controlled substances.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under to 21 U.S.C. 952(a)(2). Authorization will not extend to the
import of FDA approved or non-approved finished dosage forms for
commercial sale.
[[Page 15571]]
Dated: March 14, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-06548 Filed 3-22-16; 8:45 am]
BILLING CODE 4410-09-P